Products In
the beginning of 2004, µTBC products and customized product applications became available in the following areas: Drug Safety:
- Metabolic Profiling µTBC
for the detection of nephrotoxic and hepatotoxic target substances / metabolites of cardiovascular and oncology drugs
- Adverse Event Profiling µTBC
for cardiovascular and oncology drugs as well as antibody-based biologicals
Near-Patient Diagnostics/Point-of-Care:
- Cardiovascular analytes available on request
Product and customer references available on request.
|
![[Home]](../../_Home__NClearbutton20.gif){kind=small}
![[Preventor History]](../../_Kompetenz-Zentren_/_Preventor_History__NClearbutton20.gif){kind=small}
![[Locations & Management]](../../_Kompetenz-Zentren_/_Locations___Management__NClearbutton20.gif){kind=small}
![[Business Areas]](../../_Kompetenz-Zentren_/_Business_Areas__NClearbutton20.gif){kind=small}
![[µTBC Definition]](../../_Kompetenz-Zentren_/_muTBC_Definition__NClearbutton20.gif){kind=small}
![[Technology]](../../_Kompetenz-Zentren_/_Technology__NClearbutton20.gif){kind=small}
![[Products]](../../_Kompetenz-Zentren_/_Products_/_Products__HClearbutton20.gif){kind=small}
![[Competence Centres]](../../_Kompetenz-Zentren_/_Competence_Centres__NClearbutton20.gif){kind=small}
![[Links]](../../_Kompetenz-Zentren_/_Links__NClearbutton20_1.gif){kind=small}
![[Literature References]](../../_Kompetenz-Zentren_/_Literature_References__NClearbutton20.gif){kind=small}
![[News]](../../_Kompetenz-Zentren_/_News__NClearbutton20.gif){kind=small}
![[Contacts]](../../_Kompetenz-Zentren_/_Contacts__NClearbutton20.gif){kind=small}
![[Impressum & Legal Disclaimer]](../../_Kompetenz-Zentren_/_Impressum___Legal_Disclaimer__NClearbutton20.gif){kind=small}
